# reload+after+2024-01-23 08:44:09.773511
address1§2401 South Foothill Drive
address2§Suite D
city§Salt Lake City
state§UT
zip§84109
country§United States
phone§801 438 1036
website§https://www.codiagnostics.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
fullTimeEmployees§145
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Dwight H. Egan', 'age': 70, 'title': 'Chairman, CEO & President', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 512391, 'exercisedValue': 0, 'unexercisedValue': 71000}, {'maxAge': 1, 'name': 'Mr. Brian L. Brown CPA', 'age': 47, 'title': 'CFO & Company Secretary', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 387522, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Brent C. Satterfield Ph.D.', 'age': 46, 'title': 'Co-Founder & Member of Scientific Advisory Board', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 237500, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Dan  Bohrer CPA', 'title': 'Vice President of Finance & Accounting', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mark  Poritz Ph.D.', 'title': 'Chief Scientific Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew  Benson', 'title': 'Head of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Mayuranki  Almaula', 'title': 'Senior Vice President of Overseas Operations & Strategic Alliances', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Cameron  Gundry', 'title': 'Head of Commercialization LATAM/EUR', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ivory  Chang', 'title': 'Chief Regulatory Affairs Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§10
compensationRisk§8
shareHolderRightsRisk§5
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.724
priceToSalesTrailing12Months§8.534184
currency§USD
dateShortInterest§1702598400
forwardEps§-1.0
exchange§NCM
quoteType§EQUITY
shortName§Co-Diagnostics, Inc.
longName§Co-Diagnostics, Inc.
firstTradeDateEpochUtc§1499866200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a66500d7-07e3-3cc2-8d0a-703f2a3c6952
gmtOffSetMilliseconds§-18000000
targetHighPrice§3.0
targetLowPrice§3.0
targetMeanPrice§3.0
targetMedianPrice§3.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§12.845
grossMargins§0.628
ebitdaMargins§0.0
trailingPegRatio§None
